FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Annick Ludwig

Research Profile

Chemicals & Drugs

Concepts & Ideas

Particle Size

Objects

Nanoparticles

Phenomena

Activities & Behaviors

Rheology

Procedures

Drug Compounding

Occupations

Co-author Network

Publications

TOP 3
Kris Hermans; Dave Van den Plas; Wim Weyenberg; Arnout Everaert; Annick Ludwig
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
H Van de Ven; Guy Van den Mooter; Wim Weyenberg; Paul Cos; P B Feijens; P Kayaert; Louis Maes; A Matheeussen; C Paulussen; Patrick Rombaut; Annick Ludwig
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome.
H Van de Ven; Sandra Apers; Jo Vandervoort; Wim Weyenberg; Annick Ludwig
Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Annick Ludwig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kris Hermans; Dave Van den Plas; Wim Weyenberg; Arnout Everaert; Annick Ludwig
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;82(1):27-35.
2012: H Van de Ven; Guy Van den Mooter; Wim Weyenberg; Paul Cos; P B Feijens; P Kayaert; Louis Maes; A Matheeussen; C Paulussen; Patrick Rombaut; Annick Ludwig
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome.
Journal of controlled release : official journal of the Controlled Release Society 2012;161(3):795-803.
2012: H Van de Ven; Sandra Apers; Jo Vandervoort; Wim Weyenberg; Annick Ludwig
Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
Journal of microencapsulation 2012;29(2):115-25.
2011: H Van de Ven; Jo Vandervoort; M Vermeersch; Wim Weyenberg; Sandra Apers; Paul Cos; Louis Maes; A Matheeussen; Annick Ludwig
PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
International journal of pharmaceutics 2011;420(1):122-32.
2011: Krassimira Yoncheva; Jo Vandervoort; Annick Ludwig
Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application.
Pharmaceutical development and technology 2011;16(1):29-35.
2010: H Van de Ven; L Van Dyck; Wim Weyenberg; L Maes; Annick Ludwig
Nanosuspensions of chemically modified saponins: reduction of hemolytic side effects and potential tool in drug targeting strategy.
Journal of controlled release : official journal of the Controlled Release Society 2010;148(1):e122-3.
2010: S Bozdag; Wim Weyenberg; Els Adriaens; Marijke M M Dhondt; Valentijn G.L.P. Vergote; Chris Vervaet; K De Prijck; Hans J Nelis; B De Spiegeleer; Annick Ludwig; Jean Paul Remon
In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops.
Drug development and industrial pharmacy 2010;36(11):1259-70.
2009: H Van de Ven; M Vermeersch; T Shunmugaperumal; Jo Vandervoort; L Maes; Annick Ludwig
Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins.
Die Pharmazie 2009;64(3):172-6.
2008: Shunmugaperumal Tamilvanan; Narayanan Venkateshan; Annick Ludwig
The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
Journal of controlled release : official journal of the Controlled Release Society 2008;128(1):2-22.
2008: Kathleen Dillen; Chris H Bridts; Pieter Van der Veken; Paul Cos; Jo Vandervoort; Koen Augustyns; Wim Stevens; Annick Ludwig
Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas.
International journal of pharmaceutics 2008;349(1-2):234-40.
2008: Jo Vandervoort; Annick Ludwig
Microneedles for transdermal drug delivery: a minireview.
Frontiers in bioscience : a journal and virtual library 2008;13():1711-5.
2007: Wim Weyenberg; Plamen Filev; Dave Van den Plas; Jo Vandervoort; Kris De Smet; Philippe Sollie; Annick Ludwig
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application.
International journal of pharmaceutics 2007;337(1-2):291-8.
2007: Jo Vandervoort; Annick Ludwig
Ocular drug delivery: nanomedicine applications.
Nanomedicine (London, England) 2007;2(1):11-21.
2006: Wim Weyenberg; Philippe Sollie; Annick Ludwig
Influence of the concentrations of liposomes and a submicron emulsion on the rheological properties of a topical gel.
Die Pharmazie 2006;61(11):938-42.
2006: Kathleen Dillen; Jo Vandervoort; Guy Van den Mooter; Annick Ludwig
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
International journal of pharmaceutics 2006;314(1):72-82.
2006: Wim Weyenberg; S Bozdag; P Foreman; Jean Paul Remon; Annick Ludwig
Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2006;62(2):202-9.
2005: Annick Ludwig
The use of mucoadhesive polymers in ocular drug delivery.
Advanced drug delivery reviews 2005;57(11):1595-639.
2005: S Bozdag; Wim Weyenberg; Annick Ludwig
Rheological evaluation of dispersions, prepared with different non- and gamma-irradiated bioadhesive cospray dried powder mixtures.
Die Pharmazie 2005;60(8):593-7.
2005: S Bozdag; Kathleen Dillen; Jo Vandervoort; Annick Ludwig
The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
The Journal of pharmacy and pharmacology 2005;57(6):699-707.
2005: Wim Weyenberg; An Vermeire; Jo Vandervoort; Jean Paul Remon; Annick Ludwig
Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;59(3):527-36.
2005: Wim Weyenberg; An Vermeire; Jean Paul Remon; Annick Ludwig
Development and evaluation of sustained release ocular minitablets.
Journal of controlled release : official journal of the Controlled Release Society 2005;101(1-3):371-4.
2005: Kathleen Dillen; Jo Vandervoort; Annick Ludwig
Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use.
Journal of controlled release : official journal of the Controlled Release Society 2005;101(1-3):369-71.
2004: Jo Vandervoort; Krassimira Yoncheva; Annick Ludwig
Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
Chemical & pharmaceutical bulletin 2004;52(11):1273-9.
2004: Kathleen Dillen; Wim Weyenberg; Jo Vandervoort; Annick Ludwig
The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(3):539-49.
2004: Wim Weyenberg; An Vermeire; Marijke M M Dhondt; Els Adriaens; Philippe Kestelyn; Jean Paul Remon; Annick Ludwig
Ocular bioerodible minitablets as strategy for the management of microbial keratitis.
Investigative ophthalmology & visual science 2004;45(9):3229-33.
2004: Wim Weyenberg; An Vermeire; Eva D'Haese; Gauthier C A M Vanhaelewyn; Philippe Kestelyn; Freddy J Callens; Hans J Nelis; Jean Paul Remon; Annick Ludwig
Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;23(1):77-87.
2004: Kathleen Dillen; Jo Vandervoort; Guy Van den Mooter; Loes Verheyden; Annick Ludwig
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.
International journal of pharmaceutics 2004;275(1-2):171-87.
2004: Jo Vandervoort; Annick Ludwig
Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(2):251-61.
2004: Luc Van Santvliet; Annick Ludwig
Determinants of eye drop size.
Survey of ophthalmology 2004;49(2):197-213.
2004: Wim Weyenberg; V Todorov; Annick Ludwig
Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design.
Die Pharmazie 2004;59(2):121-5.
2003: Krassimira Yoncheva; Jo Vandervoort; Annick Ludwig
Influence of process parameters of high-pressure emulsification method on the properties of pilocarpine-loaded nanoparticles.
Journal of microencapsulation 2003;20(4):449-58.
2003: Margit Hornof; Wim Weyenberg; Annick Ludwig; Andreas Bernkop-Schnürch
Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans.
Journal of controlled release : official journal of the Controlled Release Society 2003;89(3):419-28.
2003: Wim Weyenberg; An Vermeire; Jean Paul Remon; Annick Ludwig
Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces.
Journal of controlled release : official journal of the Controlled Release Society 2003;89(2):329-40.
2002: Wim Weyenberg; Annick Ludwig
In vitro assessment of the interaction mechanisms between mucin and a cationic cellulosic derivative by rheological methods using an experimental design.
Die Pharmazie 2002;57(9):628-31.
2002: Jens Ceulemans; Annick Ludwig
Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(1):41-50.
2002: Jo Vandervoort; Annick Ludwig
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
International journal of pharmaceutics 2002;238(1-2):77-92.
2002: Jens Ceulemans; Inge Vinckier; Annick Ludwig
The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin.
Journal of pharmaceutical sciences 2002;91(4):1117-27.
2002: Jens Ceulemans; Annick Ludwig
Development of a rheometric technique to measure the mucoadhesive capacity of a dry powder formulation.
Die Pharmazie 2002;57(3):181-5.
2001: Jens Ceulemans; An Vermeire; Els Adriaens; Jean Paul Remon; Annick Ludwig
Evaluation of a mucoadhesive tablet for ocular use.
Journal of controlled release : official journal of the Controlled Release Society 2001;77(3):333-44.
2001: Jo Vandervoort; Annick Ludwig
Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study.
Die Pharmazie 2001;56(6):484-8.
1999: Luc Van Santvliet; Annick Ludwig
Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;7(4):339-45.
1998: Luc Van Santvliet; Annick Ludwig
The influence of penetration enhancers on the volume instilled of eye drops.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;45(2):189-98.